Antitumor Effect of DT-5461, a Lipid a Derivative, Against Human Tumor Xenografts Is Mediated by Intratumoral Production of Tumor Necrosis Factor and Affected by Host Immunosuppressive Factors in Nude Mice

References

• Kusama T, Soga T, Ono Y, et al. Synthesis and biological activities of lipid A analogs: Modification of a glycosidically bound group with chemically stable polar acidic groups and lipophilic groups on the disaccharide backbone with tetradecanoy or N-dodecanoylglycyl groups. Chem Pharni Bull 1991; 39: 3244–3253
   PubMed Web of Science ®Google Scholar
• Kumazawa E, Tohgo A, Soga T, et al. Significant antitumor effect of a synthetic lipid A analogue, DT-5461, on murine syngeneic tumor models. Cancer Immunol Immunother 1992; 35: 307–314
   PubMed Web of Science ®Google Scholar
• Akimoto T, Kumazawa E, Jimbo T, et al. Antitumor effect of DT-5461a, a synthetic low-toxicity lipid A analog, involves endogenous tumor necrosis factor induction subsequent to macrophage activation. Int J Immunopharmacol 1994; 11: 887–893
   Google Scholar
• Kumazawa E, Akimoto T, Kita Y, et al. Intratumoral production of tumor necrosis factor augmented by endogenous interferons results in potent antitumor effects of DT-5461, a synthetic lipid A analog. J Immunother 1995; 17: 141–150
   Web of Science ®Google Scholar
• Pantelouris E M. Absence of thymus in a mouse mutant. Nature 1968; 217: 370–371
   PubMed Web of Science ®Google Scholar
• Saito M, Ichimura O, Kataoka M, et al. Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation. Cancer Immunol Immunother 1986; 22: 161–168
   PubMed Web of Science ®Google Scholar
• Maeda Y Y, Hamuro J, Chihara G. Mechanisms of action of antitumor polysaccharides. I. The effect of antilymphocyte serum on the antitumor activity of lentinan. Int J Cancer 1971; 8: 41–46
   PubMed Web of Science ®Google Scholar
• Maeda Y Y, Chihara G. The effects of neonatal thymectomy on the anti-tumor activity of lentinan, carboxymethylphachy and zymozan, and their effects on various immune responses. Int J Cancer 1973; 11: 153–156
   PubMed Web of Science ®Google Scholar
• Giavazzi R, Garofalo A, Damia G, et al. Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. Br J Cancer 1988; 57: 277–280
   PubMed Web of Science ®Google Scholar
• Jimbo T, Akimoto T, Tohgo A. Effect of combined administration of a synthetic low-toxicity lipid A derivative, DT-5461a, and indomethacin in various experimental tumor models of colon 26 carcinoma in mice. Cancer Immunol Immunother 1995; 40: 10–16
   PubMed Web of Science ®Google Scholar
• Ruff M R, Gifford G E. Purification and physico-chemical characterization of rabbit tumor necrosis factor. J Immunol 1980; 125: 1671–1677
   PubMed Web of Science ®Google Scholar
• Kawai T, Satomi N, Sato N, et al. Effects of tumor necrosis factor (TNF) on transplanted tumors induced by methylcholanthrene in mice. A histopathological study. Virchows Arch (Cell Pathol) 1987; 52: 489–500
   Google Scholar
• Akimoto T, Kumazawa E, Jimbo T, et al. DT-5461a, an antitumor synthetic lipid A analog, causes selective blood flow reduction in tumor tissue. Anticancer Res 1995; 15: 105–108
   PubMed Web of Science ®Google Scholar
• Hasday J D, Shah E M, Lieberman A P. Macrophage tumor necrosis factor-üaL release is induced by contact with some tumors. J Immunol 1990; 145: 371–379
   PubMed Web of Science ®Google Scholar
• Tomasi J B. Regulatory Mechanism in Lymphocyte Activation. Academic Press, New York 1977
   Google Scholar
• Shibata Y, Tamura K, Ishida N. In vivo analysis of the suppressive effects of immunosuppressive acidic protein, a type of üaL-acid glycoprotein, in connection with its high level in tumor-bearing mice. Cancer Res 1983; 43: 2889–2896
   PubMed Web of Science ®Google Scholar
• Fulton A M, Levy J G. The possible role of prostaglandins in mediating immune suppression by nonspecific T suppressor cells. Cell Immunol 1980; 52: 29–37
   PubMed Web of Science ®Google Scholar
• Kemp J, Louie D, Mattingly J, et al. Suppressor cells in vitro: Differential effects of indomethacin and related compounds. J Immunopharmacol 1980; 2: 471–489
   PubMed Web of Science ®Google Scholar
• Pelus L M, Strausser H R. Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer 1976; 18: 653–660
   PubMed Web of Science ®Google Scholar
• Plescia O J, Smith A H, Grinwick K. Subversion of immune systems by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 1975; 72: 1848–1851
   PubMed Web of Science ®Google Scholar
• Renz H, Gong J H, Schmidt A, et al. Release of tumor necrosis factor-a from macrophages enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J Immunol 1988; 141: 2388–2393
   PubMed Web of Science ®Google Scholar
• Young M R, Wheeler E, Newby M. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma. J Natl Cancer Inst 1986; 76: 745–750
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Tanaka T, Ishitsuka H. Antitumor activity of indomethacin in mice bearing advanced colon 26 carcinoma compared with early transplants. Cancer Res 1989; 49: 5935–5939
   PubMed Web of Science ®Google Scholar